Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

Second-generation antihistamines: the risk of ventricular arrhythmias.

DuBuske LM.

Clin Ther. 1999 Feb;21(2):281-95. Review.

PMID:
10211532
2.

Pharmacokinetic overview of oral second-generation H1 antihistamines.

González MA, Estes KS.

Int J Clin Pharmacol Ther. 1998 May;36(5):292-300. Review.

PMID:
9629995
3.
4.

Cardiovascular toxicity of antihistamines.

Smith SJ.

Otolaryngol Head Neck Surg. 1994 Sep;111(3 Pt 2):348-54. Review.

PMID:
7916150
5.
6.

Cardiac actions of antihistamines.

Woosley RL.

Annu Rev Pharmacol Toxicol. 1996;36:233-52. Review.

PMID:
8725389
7.

[The effect of second generation histamine antagonists on the heart].

Grzelewska-Rzymowska I, Pietrzkowicz M, Górska M.

Pneumonol Alergol Pol. 2001;69(3-4):217-26. Review. Polish.

PMID:
11575008
8.

Cardiovascular safety of second-generation antihistamines.

Barbey JT, Anderson M, Ciprandi G, Frew AJ, Morad M, Priori SG, Ongini E, Affrime MB.

Am J Rhinol. 1999 May-Jun;13(3):235-43.

PMID:
10392245
9.

Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.

Delgado LF, Pferferman A, Solé D, Naspitz CK.

Ann Allergy Asthma Immunol. 1998 Apr;80(4):333-7.

PMID:
9564984
10.

Safety of antihistamines in children.

Ten Eick AP, Blumer JL, Reed MD.

Drug Saf. 2001;24(2):119-47. Review.

PMID:
11235817
11.

Cardiotoxicity of new antihistamines and cisapride.

Paakkari I.

Toxicol Lett. 2002 Feb 28;127(1-3):279-84. Review.

PMID:
12052668
12.

Potential cardiac toxicity of H1-antihistamines.

Yap YG, Camm AJ.

Clin Allergy Immunol. 2002;17:389-419. Review.

PMID:
12113224
13.

Regulation of potassium channels by nonsedating antihistamines.

Berul CI, Morad M.

Circulation. 1995 Apr 15;91(8):2220-5.

14.

Preclinical in vitro cardiac electrophysiology: a method of predicting arrhythmogenic potential of antihistamines in humans?

Cavero I, Mestre M, Guillon JM, Heuillet E, Roach AG.

Drug Saf. 1999;21 Suppl 1:19-31; discussion 81-7. Review.

PMID:
10597865
15.
16.
17.

Is QT interval prolongation harmful? A regulatory perspective.

Botstein P.

Am J Cardiol. 1993 Aug 26;72(6):50B-52B.

PMID:
8256756
18.
19.

The current cardiac safety situation with antihistamines.

Yap YG, Camm AJ.

Clin Exp Allergy. 1999 Mar;29 Suppl 1:15-24. Review.

PMID:
10209701
20.

Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.

de Abajo FJ, Rodríguez LA.

Br J Clin Pharmacol. 1999 Mar;47(3):307-13.

Supplemental Content

Support Center